[avatar user=”thassodotcom” size=”thumbnail” align=”left” /] March 11, 2016 – Medscape Multispeciality just published  a CDC Expert Commentary by John W. Ward, MD, Director, Division of Viral Hepatitis, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, which addresses the double sided sword of …

Extraorbitant cost keeps HCV care out of reach for many patients: Are there profound ethical and societal issues looming? Read more »

Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Abergel A, Mangia A, Lai CL, Chan HL, Mazzotta F, Moreno C, Yoshida E, Shafran SD, Towner WJ, Tran TT, McNally J, Osinusi A, Svarovskaia E, Zhu Y, …

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection Read more »